Benicar Settles Lawsuits for $300 Million

On August 1, 2017, Daiichi Sankyo – the manufacturer of Benicar, a drug used to treat high blood pressure – settled the more than 2,300 defective drug lawsuits filed against it by agreeing to pay out $300 million to victims. If you were prescribed Benicar to treat your high blood pressure before May of 2015,…

Read More

Pharma Company Agrees to Pull Widely-Abused Opiate from Market

Opana ER was formulated to deter or prevent abuse, with a crush-proof coating that reduced addicts’ ability to inhale or “snort” the drug. However, through grating and dissolving the new coated pills, drug abusers found the medication—originally designed to provide pain relief for patients with chronic, severe, long-term pain—was now injectable, leading to a quicker…

Read More

Two Ex-Insys Saleswomen Plead Guilty in U.S. to Drug Kickback Schemes

The number of former Insys Therapeutics employees who are pleading guilty to criminal charges is increasing. A Reuters release (provided via CNBC) said that Natalie Levine and Karen Hill, “Two former Insys Therapeutics Inc sales representatives… pleaded guilty on Tuesday to engaging in schemes to pay kickbacks to medical practitioners to prescribe a drug containing…

Read More

Insys Seeks to Resolve U.S. Probe of Subsys Spray

This month, news broke that Insys Therapeutics, the makers of the fentanyl-based opioid spray Subsys were in talks with the U.S. Department of Justice to resolve their probe into the company and its predatory practices. As the country tries to mitigate its overdose and addiction crisis – much of which is perpetuated by prescription opioid…

Read More

Patty Nixon Blows the Whistle on Insys Therapeutics: NBC News Reports

Insys Therapeutics, makers of the fentanyl spray Subsys, is facing considerable pressure from authorities for their deceptive marketing practices, which could be linked to a number of opioid-related overdoses throughout the country. McGowan, Hood, Felder & Phillips, LLC, has been aggressively pursuing justice on behalf of Subsys patients, and their families, who have been wrongfully…

Read More